| Sabril 500 mg film-coated Tablets PA0540/023/001 |
Vigabatrin |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Sabril 500 mg Granules for Oral Solution PA0540/023/002 |
Vigabatrin |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Sacubitril/Valsartan Accord 24 mg/26 mg film-coated tablets PA2315/275/001 |
Sacubitril sodium, Valsartan disodium |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Sacubitril/Valsartan Accord 49 mg/51 mg film-coated tablets PA2315/275/002 |
Sacubitril sodium, Valsartan disodium |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Sacubitril/Valsartan Accord 97 mg/103 mg film-coated tablets PA2315/275/003 |
Sacubitril sodium, Valsartan disodium |
Accord Healthcare Ireland Ltd. |
Not marketed |
| Sacubitril/Valsartan Krka 24 mg/26 mg film-coated tablets PA1347/119/001 |
Sacubitril sodium, Valsartan disodium |
KRKA, d.d., Novo mesto |
Not marketed |
| Sacubitril/Valsartan Krka 49 mg/51 mg film-coated tablets PA1347/119/002 |
Sacubitril sodium, Valsartan disodium |
KRKA, d.d., Novo mesto |
Not marketed |
| Sacubitril/Valsartan Krka 97 mg/103 mg film-coated tablets PA1347/119/003 |
Sacubitril sodium, Valsartan disodium |
KRKA, d.d., Novo mesto |
Not marketed |
| Sacubitril/Valsartan Teva 24 mg/26 mg film-coated tablets PA22579/004/001 |
Sacubitril sodium, Valsartan disodium |
TEVA GmbH |
Not marketed |
| Sacubitril/Valsartan Teva 49 mg/51 mg film-coated tablets PA22579/004/002 |
Sacubitril sodium, Valsartan disodium |
TEVA GmbH |
Not marketed |
| Sacubitril/Valsartan Teva 97 mg/103 mg film-coated tablets PA22579/004/003 |
Sacubitril sodium, Valsartan disodium |
TEVA GmbH |
Not marketed |
| Saflutan 15 micrograms/ml, eye drops, solution in single-dose container PA0879/006/001 |
Tafluprost |
Santen OY |
Marketed |
| Saflutan 15 micrograms/ml, eye drops, solution in single-dose container PPA0465/324/001 |
Tafluprost |
PCO Manufacturing Ltd. |
— |
| Saizen 5.83 mg/ml solution for injection in cartridge PA2286/006/001 |
Somatropin |
Merck Serono (Ireland) Limited |
Marketed |
| Saizen 8 mg/ml solution for injection in cartridge PA2286/006/002 |
Somatropin |
Merck Serono (Ireland) Limited |
Marketed |
| Saizen 8 mg/ml solution for injection in cartridge PPA0465/506/001 |
Somatropin |
PCO Manufacturing Ltd. |
— |
| Salactol Collodion PA23128/003/001 |
Salicylic acid, Lactic acid |
Dermal Laboratories (Ireland) Limited |
Marketed |
| Salamol CFC-Free Inhaler 100 micrograms pressurised inhalation, suspension PA0436/032/001 |
Salbutamol |
Norton Waterford |
Marketed |
| Salamol Easi-Breathe CFC-Free Inhaler 100 micrograms Pressurised Inhalation, Suspension PA0436/032/002 |
SALBUTAMOL SULFATE |
Norton Waterford |
Marketed |
| Salamol Steri-Neb 2.5 mg/2.5 ml nebuliser solution PA1986/086/001 |
SALBUTAMOL SULFATE |
Teva B.V. |
Marketed |
| Salamol Steri-Neb 5 mg/2.5 ml Nebuliser Solution PA1986/086/002 |
Salbutamol |
Teva B.V. |
Marketed |
| Salatac Gel Salicylic Acid 12.0% w/w Lactic Acid 4.0% w/w PA23128/007/001 |
Salicylic acid, Lactic acid |
Dermal Laboratories (Ireland) Limited |
Marketed |
| Salazopyrin EN Tabs 500 mg Gastro-resistant tablets PPA0465/160/001 |
Sulfasalazine |
PCO Manufacturing Ltd. |
— |
| Salazopyrin® 500 mg Tablets PA0822/196/002 |
Sulfasalazine |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Salazopyrin® EN Tabs 500 mg Gastro-resistant tablets PA0822/196/001 |
Sulfasalazine |
Pfizer Healthcare Ireland Unlimited Company |
Marketed |
| Salbutamol Neutec 2.5 mg/2.5 ml nebuliser solution PA23030/002/001 |
SALBUTAMOL SULFATE |
Neutec Inhaler Ireland Limited |
Not marketed |
| Saline Steri-Neb 0.9% w/v Nebuliser Solution PA1986/087/001 |
Sodium chloride |
Teva B.V. |
Marketed |
| Salmeterol/Fluticasone 50 microgram/100 microgram/dose inhalation powder, pre-dispensed PA23010/004/001 |
SALMETEROL XINAFOATE, Fluticasone propionate |
Genetic S.p.A. |
Not marketed |
| Salmeterol/Fluticasone 50 microgram/250 microgram/dose inhalation powder, pre-dispensed PA23010/004/002 |
SALMETEROL XINAFOATE, Fluticasone propionate |
Genetic S.p.A. |
Not marketed |
| Salmeterol/Fluticasone 50 microgram/500 microgram/dose inhalation powder, pre-dispensed PA23010/004/003 |
SALMETEROL XINAFOATE, Fluticasone propionate |
Genetic S.p.A. |
Not marketed |
| Salofalk 1.5g prolonged-release granules PA0573/003/007 |
Mesalazine |
Dr. Falk Pharma GmbH |
Marketed |
| Salofalk 1000mg prolonged-release granules PA0573/003/002 |
Mesalazine |
Dr. Falk Pharma GmbH |
Marketed |
| Salofalk 1g Suppositories PA0573/004/004 |
Mesalazine |
Dr. Falk Pharma GmbH |
Marketed |
| Salofalk 1g Suppositories PPA1463/212/001 |
Mesalazine |
IMED Healthcare Ltd., |
— |
| Salofalk 1g/Actuation Rectal Foam PA0573/004/005 |
Mesalazine |
Dr. Falk Pharma GmbH |
Marketed |
| Salofalk 250 mg Suppositories PA0573/004/002 |
Mesalazine |
Dr. Falk Pharma GmbH |
Marketed |
| Salofalk 3g prolonged-release granules PA0573/003/006 |
Mesalazine |
Dr. Falk Pharma GmbH |
Marketed |
| Salofalk 4g/60ml Enema PA0573/004/001 |
Mesalazine |
Dr. Falk Pharma GmbH |
Marketed |
| Salofalk 500 mg prolonged-release granules PA0573/003/001 |
Mesalazine |
Dr. Falk Pharma GmbH |
Marketed |
| Salvacyl, 11.25 mg powder and solvent for prolonged-release suspension for injection PA0869/008/001 |
Triptorelin |
Ipsen Pharmaceuticals Limited |
Not marketed |
| Sametec Airmaster 50 microgram/ 100 microgram/ dose, inhalation powder, pre-dispensed PA0126/342/001 |
SALMETEROL XINAFOATE, Fluticasone propionate |
Clonmel Healthcare Ltd |
Marketed |
| Sametec Airmaster 50 microgram/ 250 microgram/ dose, inhalation powder, pre-dispensed PA0126/342/002 |
SALMETEROL XINAFOATE, Fluticasone propionate |
Clonmel Healthcare Ltd |
Marketed |
| Sametec Airmaster 50 microgram/ 500 microgram/ dose, inhalation powder, pre-dispensed PA0126/342/003 |
SALMETEROL XINAFOATE, Fluticasone propionate |
Clonmel Healthcare Ltd |
Marketed |
| Samsca 15 mg Tablet EU/1/09/539/1-2 |
Tolvaptan |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Samsca 30 mg Tablet EU/1/09/539/3-4 |
Tolvaptan |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Samsca 7.5 mg Tablet EU/1/09/539/005-006 |
Tolvaptan (opc-41061) |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| SANCUSO 3.1 mg/24 hours transdermal patch EU/1/12/766/001 |
Granisetron |
Grünenthal GmbH |
— |
| Sandimmun 50 mg/ml Concentrate for Solution for Infusion PA0896/027/002 |
Ciclosporin |
Novartis Ireland Limited |
Marketed |
| SANDOSTATIN 100 microgram/1ml, solution for injection/infusion PA0896/028/002 |
Octreotide |
Novartis Ireland Limited |
Marketed |
| SANDOSTATIN 50 microgram/1 ml, solution for injection/infusion PA0896/028/001 |
Octreotide |
Novartis Ireland Limited |
Marketed |